Acknowledgment for APICES collaboration in a rectal cancer phase II trial

We want to share the acknowledgment that APICES has received in a rectal cancer phase II trial in the recent paper published in American Journal of Clinical Oncology, in which APICES has collaborated in data management, statistical analysis, and medical writing activities.

This means a great motivation to all the APICES team to give continuity to the implication we have in every project in which we collaborate. APICES is very proud of the recognition of our work, and we would like to thank Dr. César Muñoz and Dr. Antonio Cubillo, and HM Hospital Foundation for giving us the opportunity to appear in the acknowledgments of the publication and congratulate them and all the investigators for their project success.

This Phase II clinical trial aims to evaluate the efficacy of neoadjuvant chemotherapy combining liposomal irinotecan, 5-fluorouracil, leucovorin, and oxaliplatin in patients with locally advanced rectal cancer.

You can find further information in the following link: https://journals.lww.com/amjclinicaloncology/abstract/9900/phase_2,_multicenter,_open_label,_nonrandomized.244.aspx